Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Fluorescein sodium
Bausch & Lomb UK Ltd
S01JA01
Fluorescein sodium
20mg/1ml
Eye drops
Ocular
No Controlled Drug Status
Valid as a prescribable product
BNF: 11080200; GTIN: 5027519000906
OBJECT 1 MINIMS FLUORESCEIN SODIUM 2%, EYE DROPS SOLUTION Summary of Product Characteristics Updated 28-Jul-2016 | Bausch & Lomb U.K Limited 1. Name of the medicinal product Minims Fluorescein Sodium 2% 2. Qualitative and quantitative composition 2% w/v solution of Fluorescein Sodium PhEur. 3. Pharmaceutical form Single-use, sterile eye drops. 4. Clinical particulars 4.1 Therapeutic indications Fluorescein does not stain a normal cornea but conjunctival abrasions are stained yellow or orange, corneal abrasions or ulcers are stained a bright green and foreign bodies are surrounded by a green ring. Fluorescein can be used in diagnostic examinations including Goldmann tonometry and in the fitting of hard contact lenses. 4.2 Posology and method of administration Adults, Children and the Elderly Instil dropwise into the eye. Sufficient solution should be applied to stain the damaged areas. Excess may be washed away with sterile saline solution. 4.3 Contraindications Not to be used with soft contact lenses. 4.4 Special warnings and precautions for use Special care should be taken to avoid microbial contamination. _Pseudomonas aeruginosa_ grows well in fluorescein solutions, therefore, a single dose solution is preferred. Each Minims unit should be discarded after a single use. 4.5 Interaction with other medicinal products and other forms of interaction None known. 4.6 Pregnancy and lactation Safety for use in pregnancy and lactation has not been established, therefore use only when considered essential by the physician. 4.7 Effects on ability to drive and use machines May cause transient blurring of vision on instillation. Warn patients not to drive or operate hazardous machinery until vision is clear. 4.8 Undesirable effects ADRs are very rare(<1/10,000),including isolated reports. Symptoms of allergic-type reactions and anaphylaxis have been reported following topical ophthalmic administration of Fluorescein sodium and may manifest as: Eye disorders: allergic conjunctivitis, peri-orbital oedema Immune system disorder read_full_document